# Are Nexus AG (ETR:NXU) Investors Paying Above The Intrinsic Value?

## Limited Time Offer!

For Less Than the Cost of a Starbucks Coffee, Access All DevOpsSchool Videos on YouTube Unlimitedly.
**Master DevOps, SRE, DevSecOps Skills!**

Source: simplywall.st

How far off is Nexus AG (ETR:NXU) from its intrinsic value? Using the most recent financial data, we’ll take a look at whether the stock is fairly priced by taking the foreast future cash flows of the company and discounting them back to today’s value. I will be using the Discounted Cash Flow (DCF) model. Don’t get put off by the jargon, the math behind it is actually quite straightforward.

We generally believe that a company’s value is the present value of all of the cash it will generate in the future. However, a DCF is just one valuation metric among many, and it is not without flaws. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.

### Is Nexus fairly valued?

We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company’s cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren’t available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.

Generally we assume that a dollar today is more valuable than a dollar in the future, so we discount the value of these future cash flows to their estimated value in today’s dollars:

#### 10-year free cash flow (FCF) forecast

2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |

Levered FCF (€, Millions) | €21.3m | €23.3m | €20.6m | €21.8m | €21.7m | €21.7m | €21.7m | €21.7m | €21.8m | €21.8m |

Growth Rate Estimate Source | Analyst x4 | Analyst x4 | Analyst x1 | Analyst x1 | Est @ -0.26% | Est @ -0.11% | Est @ -0.01% | Est @ 0.06% | Est @ 0.11% | Est @ 0.15% |

Present Value (€, Millions) Discounted @ 6.56% | €19.9 | €20.5 | €17.0 | €16.9 | €15.8 | €14.8 | €13.9 | €13.1 | €12.3 | €11.5 |

*(“Est” = FCF growth rate estimated by Simply Wall St)* **Present Value of 10-year Cash Flow (PVCF)**= €155.8m

The second stage is also known as Terminal Value, this is the business’s cash flow after the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country’s GDP growth. In this case we have used the 10-year government bond rate (0.2%) to estimate future growth. In the same way as with the 10-year ‘growth’ period, we discount future cash flows to today’s value, using a cost of equity of 6.6%.

**Terminal Value (TV)** = FCF_{2029} × (1 + g) ÷ (r – g) = €22m × (1 + 0.2%) ÷ (6.6% – 0.2%) = €345m

**Present Value of Terminal Value (PVTV)** = TV / (1 + r)^{10} = €€345m ÷ ( 1 + 6.6%)^{10} = €182.45m

The total value is the sum of cash flows for the next ten years plus
the discounted terminal value, which results in the Total Equity Value,
which in this case is €338.26m. To get the intrinsic value per share, we
divide this by the total number of shares outstanding. **This results in an intrinsic value estimate of €21.53**.
Relative to the current share price of €28.1, the company appears
potentially overvalued at the time of writing. Remember though, that
this is just an approximate valuation, and like any complex formula –
garbage in, garbage out.

### Important assumptions

Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don’t agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company’s future capital requirements, so it does not give a full picture of a company’s potential performance. Given that we are looking at Nexus as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we’ve used 6.6%, which is based on a levered beta of 1.063. Beta is a measure of a stock’s volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.

### Next Steps:

Whilst important, DCF calculation shouldn’t be the only metric you look at when researching a company. The DCF model is not a perfect stock valuation tool. Rather it should be seen as a guide to “what assumptions need to be true for this stock to be under/overvalued?” If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price to differ from the intrinsic value? For Nexus, There are three further factors you should further examine:

**Financial Health**: Does NXU have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.**Future Earnings**: How does NXU’s growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.**Other High Quality Alternatives**: Are there other high quality stocks you could be holding instead of NXU? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing!

PS. Simply Wall St updates its DCF calculation for every DE stock every day, so if you want to find the intrinsic value of any other stock just search here.

*We
aim to bring you long-term focused research analysis driven by
fundamental data. Note that our analysis may not factor in the latest
price-sensitive company announcements or qualitative material.*